US FDA Cell And Gene Therapy Regulation “Must Evolve,” OTP Acting Director Kumar Says

 
• By Michael McCaughan
  
Some challenges with cell and gene therapies require collaborative solutions, Acting OTP Director Vijay Kumar said. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from United States